These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 29039058)
41. Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry. Pippias M; Stel VS; Aresté-Fosalba N; Couchoud C; Fernandez-Fresnedo G; Finne P; Heaf JG; Hoitsma A; De Meester J; Pálsson R; Ravani P; Segelmark M; Traynor JP; Reisæter AV; Caskey FJ; Jager KJ Transplantation; 2016 Sep; 100(9):1955-62. PubMed ID: 26588008 [TBL] [Abstract][Full Text] [Related]
42. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411 [TBL] [Abstract][Full Text] [Related]
43. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival. Cosio FG; Frankel WL; Pelletier RP; Pesavento TE; Henry ML; Ferguson RM Am J Kidney Dis; 1999 Oct; 34(4):731-8. PubMed ID: 10516356 [TBL] [Abstract][Full Text] [Related]
44. Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. Hariharan S; Peddi VR; Savin VJ; Johnson CP; First MR; Roza AM; Adams MB Am J Kidney Dis; 1998 Jun; 31(6):928-31. PubMed ID: 9631835 [TBL] [Abstract][Full Text] [Related]
45. Focal and segmental glomerulosclerosis in renal allograft recipients: a clinico-pathologic study of 37 cases. Gupta R; Sharma A; Mahanta PJ; Agarwal SK; Dinda AK Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):8-14. PubMed ID: 23354185 [TBL] [Abstract][Full Text] [Related]
46. Glomerulonephritis is the major cause of proteinuria in renal transplant recipients: histopathologic findings of renal allografts with proteinuria. Chung J; Park SK; Park JS; Kim SC; Han DJ; Yu E Clin Transplant; 2000 Oct; 14(5):499-504. PubMed ID: 11048996 [TBL] [Abstract][Full Text] [Related]
47. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts. Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079 [TBL] [Abstract][Full Text] [Related]
48. Risk of renal allograft loss from recurrent glomerulonephritis. Briganti EM; Russ GR; McNeil JJ; Atkins RC; Chadban SJ N Engl J Med; 2002 Jul; 347(2):103-9. PubMed ID: 12110738 [TBL] [Abstract][Full Text] [Related]
49. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents. Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461 [TBL] [Abstract][Full Text] [Related]
50. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Odorico JS; Knechtle SJ; Rayhill SC; Pirsch JD; D'Alessandro AM; Belzer FO; Sollinger HW Transplantation; 1996 Jan; 61(2):228-34. PubMed ID: 8600629 [TBL] [Abstract][Full Text] [Related]
51. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies. Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301 [TBL] [Abstract][Full Text] [Related]
53. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence. Pham PT; Pham PC Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327 [TBL] [Abstract][Full Text] [Related]